Targeting Dermal Fibroblast Subtypes in Antifibrotic Therapy: Surface Marker as a Cellular Identity or a Functional Entity?
Targeting Dermal Fibroblast Subtypes in Antifibrotic Therapy: Surface Marker as a Cellular Identity or a Functional Entity?
复制标题
抗纤维化治疗中针对真皮成纤维细胞亚型:表面标记作为细胞身份还是功能实体?
DOI:
10.3389/fphys.2021.694605
复制
发表时间:
2021
影响因子:
4
通讯作者:
Zan T
中科院分区:
文献类型:
--
作者:
Huang X;Khoong Y;Han C;Su D;Ma H;Gu S;Li Q;Zan T
Fibroblasts are the chief effector cells in fibrotic diseases and have been discovered to be highly heterogeneous. Recently, fibroblast heterogeneity in human skin has been studied extensively and several surface markers for dermal fibroblast subtypes have been identified, holding promise for future antifibrotic therapies. However, it has yet to be confirmed whether surface markers should be looked upon as merely lineage landmarks or as functional entities of fibroblast subtypes, which may further complicate the interpretation of cellular function of these fibroblast subtypes. This review aims to provide an update on current evidence on fibroblast surface markers in fibrotic disorders of skin as well as of other organ systems. Specifically, studies where surface markers were treated as lineage markers and manipulated as functional membrane proteins are both evaluated in parallel, hoping to reveal the underlying mechanism behind the pathogenesis of tissue fibrosis contributed by various fibroblast subtypes from multiple angles, shedding lights on future translational researches.
登录
查看更多内容
影响因子:
--
作者:
Chen WC;Chang YS;Hsu HP;Yen MC;Huang HL;Cho CY;Wang CY;Weng TY;Lai PT;Chen CS;Lin YJ;Lai MD
通讯作者:
Lai MD
影响因子:
64.8
作者:
通讯作者:
--
影响因子:
10.8
作者:
Bessi, Valrie L.;Labbe, Sebastien M.;Marleau, Sylvie
通讯作者:
Marleau, Sylvie
影响因子:
7.7
作者:
Aroor AR;Habibi J;Ford DA;Nistala R;Lastra G;Manrique C;Dunham MM;Ford KD;Thyfault JP;Parks EJ;Sowers JR;Rector RS
通讯作者:
Rector RS
影响因子:
15.9
作者:
Febbraio, M;Hajjar, DP;Silverstein, RL
通讯作者:
Silverstein, RL